Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma.
Kenner-Bell
Brandi M
BM
Paller
Amy S
AS
Lacouture
Mario E
ME
D000328:Adult; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D005260:Female; D006229:Hand Dermatoses / Q000188:drug therapy*; D006801:Humans; D007645:Keratoderma, Palmoplantar / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors